Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant

Go back to Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
(NASDAQ: COCH) Delayed: 0.66 -0.03 (4.35%)
Previous Close $0.69    52 Week High
Open $0.69    52 Week Low
Day High $0.69    P/E N/A 
Day Low $0.66    EPS
Volume 150,803